ArticleCirculation2019

Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial.

Marat Fudim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.